Color Vision Test for Early Detection of Antiepileptic Drug Toxicity
Neurol 48:1394-1397, Bayer,A.U.,et al, 1997
Tizanidine for Spasticity
The Medical Letter 39:62, , 1997
Dietary Antioxidants and Parkinson Disease
Arch Neurol 54:762-765, deRijk,M.C.,et al, 1997
Severe but Transient Parkinsonism after Tetanus Vaccination
JNNP 63:258, Reijneveld,J.C.,et al, 1997
Gabapentin for Idiopathic Trigeminal Neuralgia:Report of Two Cases
Neurol 48:1467, Sist,T.,et al, 1997
Risk Factors for Postherpetic Neuralgia
Arch Int Med 157:1217-1224, 11661997., Choo,P.W.,et al, 1997
The Effect of Treating Herpes Zoster with Oral Acyclovir in Preventing Postherpetic Neuralgia
Arch Int Med 157:909-912, Jackson,J.L.,et al, 1997
The Effect of Antenatal Phenobarbital Therapy on Neonatal Intracranial Hemorrhage in Preterm Infants
NEJM 337:466-471, Shankaran,S.,et al, 1997
Should One Reinsert the Stylet During Lumbar Puncture
NEJM 336:1190, Strupp,M.&Brandt,T., 1997
Assessment of the Efficacy of Noninvasive Screening for Patients with Asymptomatic Neck Bruits
Stroke 28:1330-1339, Obuchowski,N.A.,et al, 1997
Why Would You Remove Half a Brain? Outcome of 58 Children after Hemispherectomy-Johns Hopkins 1968-96
Pediatrics 100:163-171, Vining,E.P.G.,et al, 1997
Clinicopath Conf
Dysembryoplastic Neuroepithelial Tumor, Case 14-1997, NEJM 336:1373-1379997., , 1997
Seizures, Epilepsy, and Functional Recovery after Traumatic Brain Injury
Neurol 48:803-806, Hernandez,T.D.&Naritoku,D.K., 1997
Gabapentin Monotherapy:An 8-Day, Study in Hosp Pts with Refractory Complex Partial or Secondarily Gen Seizures
Neurol 49:739-745, Bergey,G.K.,et al, 1997
Choreoathetosis as a Side Effect of Gabapentin Therapy in Severely Neurologically Impaired Patients
Arch Neurol 54:910-912, Chudnow,R.S.,et al, 1997
Gabapentin and Cognition:A Double Blind, Dose Ranging, Placebo Controlled Study in Refractory Epilepsy
JNNP 62:372-376, Leach,J.P.,et al, 1997
Incontinence During Treatment with Gabapentin
Neurol 48:1467-1468, Gil-Nagel,A.,et al, 1997
Assessment of Vagus Nerve Stimulation for Epilepsy
Neurol 49:293-297, Fisher,R.S.,et al, 1997
Risk of Serious Cutaneous Disorders after Initiation of Use of Phenytoin, Carbamazepine, or Sodium Valproate
Neurol 49:542-546, Tennis,P.&Stern,R.S., 1997
Focal Cortical Dysplasia:Appearance on MR Images
Radiology 203:553-559, Yagishita,A.,et al, 1997
Bacterial Meningitis in the United States in 1995
NEJM 337:970-976, Schuchat,A.,et al, 1997
Surgical Closure of Patent Foramen Ovale in Cryptogenic Stroke Patients
Stroke 28:2376-2381, Homma,S.,et al, 1997
1997 USPHS/IDSA Guidelines for Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus
Ann Int Med 127:923-946, , 1997
Cerebral Tuberculosis in Pts with AIDS, Report of 6 Cases & Review
Medicine 76:423-431, Lesprit,P.,et al, 1997
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
Clin Features of Early-Onset Alzheimer Disease in Large Kindred with an E280A Presenilin-1 Mutation
JAMA 277:793-799, Lopera,F.,et al, 1997
Measles Vaccination and Guillain-Barre Syndrome
349:14-16, daSilveira,C.M.,et al, 1997
Adult-Onset Temporal Lobe Epilepsy Associated with Smoldering Herpes Simplex 2 Infection
Neurol 48:425-430, Cornford,M.E.&McCormick,G.F., 1997
HIV Infection-1
BMJ 314:487-491, 579-5831997., Cohn,J.A., 1997
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997
Epidemiology, Pathophysiology, & Management of Hyponatremic Encephalopathy
Am J Med 102:67-77, Fraser,C.L.,et al, 1997
Familial episodic Ataxia:Clinical Heterogeneity in Four Families Linked to Chromosome 19p
Ann Neurol 41:8-16, 41997., Baloh,R.W.,et al, 1997
Risk of Alzheimer's Disease and Duration of NSAID Use
Neurol 48:626-632, Stewart,W.F.,et al, 1997
Neurological Disturbances Due to Filgrastim
Lancet 349:402-403, Schrijvers,D.,et al, 1997
A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of Influenza Immunizaation in MS
Neurol 48:312-314, Miller,A.E.,et al, 1997
HIV-1 Protease Inhibitors
JAMA 227:145-149, Deeks,S.J.,et al, 1997
Diagnosis of AIDS-Related Focal Brain Lesions
Neurol 48:687-694, Antinori,A.,et al, 1997
Neurologic Complic of Treat of Childhood Acute Immune Thrombocytopenic Purpura with IVIG
J Pediatr 130:281-283, Kattamis,A.C.,et al, 1997
Is There a Gulf War Syndrome? Searching for Syndromes by Factor Analysis of Symptoms
JAMA 227:215-222, 2591997., Haley,R.W.,et al, 1997
Self-Reported Exposure to Neurotoxic Chemical Combinations in the Gulf War:A Cross-Sectional Epidemiologic Study
JAMA 227:231-237, 2591997., Haley,R.W.&Kurt,T.L., 1997
Familial Acephalgic Migraines
Neurol 48:776-777, Shevell,M.I., 1997
Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997
Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997
Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997
Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997
Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997
Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
NEJM 336:1216-1222, 12451997., Sano,M.,et al, 1997
Antioxidants and Dementia
Lancet 349:1189-1190, Lethem,R.&Orrell,M., 1997